Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:54 pm Purchase |
2024-12-31 | 13G | Poseida Therapeutics, Inc. PSTX |
NOMURA HOLDINGS INC | 5,115,015 5.200% |
5,115,015 (New Position) |
Filing History |
| 2025-02-07 10:23 am Sale |
2025-01-31 | 13G | Poseida Therapeutics, Inc. PSTX |
FMR CORP | 0 0.000% |
-10,011,617 (Position Closed) |
Filing History |
| 2025-02-07 10:06 am Sale |
2024-12-31 | 13G | Poseida Therapeutics, Inc. PSTX |
FMR CORP | 10,011,617 10.300% |
-4,332,048 (-30.20%) |
Filing History |
| 2025-01-15 4:27 pm Sale |
2025-01-08 | 13G | Poseida Therapeutics, Inc. PSTX |
Malin Life Sciences Holdings Limited | 0 0.000% |
-9,188,125 (Position Closed) |
Filing History |
| 2025-01-13 4:05 pm Sale |
2025-01-08 | 13D | Poseida Therapeutics, Inc. PSTX |
Pentwater Capital Management LP | 0 0.000% |
-8,625,000 (Position Closed) |
Filing History |
| 2024-11-27 7:01 pm Purchase |
2024-11-25 | 13D | Poseida Therapeutics, Inc. PSTX |
Pentwater Capital Management LP | 8,625,000 8.800% |
3,657,773 (+73.64%) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Poseida Therapeutics, Inc. PSTX |
BLACKROCK INC BLK |
5,123,969 5.300% |
0 (Unchanged) |
Filing History |
| 2024-10-22 3:24 pm Purchase |
2024-09-30 | 13G | Poseida Therapeutics, Inc. PSTX |
BLACKROCK INC BLK |
5,123,969 5.300% |
296,730 (+6.15%) |
Filing History |
| 2024-06-07 1:30 pm Sale |
2024-05-31 | 13G | Poseida Therapeutics, Inc. PSTX |
BLACKROCK INC BLK |
4,827,239 4.970% |
-203,934 (-4.05%) |
Filing History |
| 2024-05-08 4:01 pm Sale |
2024-03-31 | 13G | Poseida Therapeutics, Inc. PSTX |
NOVARTIS INC | 0 0.000% |
-5,908,089 (Position Closed) |
Filing History |
| 2024-02-09 09:28 am Purchase |
2024-02-08 | 13G | Poseida Therapeutics, Inc. PSTX |
FMR CORP | 14,343,665 14.999% |
1,451,258 (+11.26%) |
Filing History |
| 2024-01-31 2:08 pm Purchase |
2023-12-31 | 13G | Poseida Therapeutics, Inc. PSTX |
BLACKROCK INC BLK |
5,031,173 5.300% |
5,031,173 (New Position) |
Filing History |
| 2023-08-14 4:41 pm Purchase |
2023-08-04 | 13D | Poseida Therapeutics, Inc. PSTX |
Astellas US LLC | 8,333,333 8.700% |
8,333,333 (New Position) |
Filing History |
| 2023-02-09 12:31 pm Purchase |
2023-02-09 | 13G | Poseida Therapeutics, Inc. PSTX |
FMR CORP | 12,892,407 14.999% |
3,516,466 (+37.51%) |
Filing History |
| 2022-04-25 4:30 pm Unchanged |
2022-04-22 | 13D | Poseida Therapeutics, Inc. PSTX |
Pentwater Capital Management LP | 4,967,227 7.940% |
0 (Unchanged) |
Filing History |
| 2022-02-09 10:24 am Purchase |
2022-02-08 | 13G | Poseida Therapeutics, Inc. PSTX |
FMR CORP | 9,375,941 14.999% |
102,940 (+1.11%) |
Filing History |
| 2021-02-12 4:24 pm Purchase |
2020-12-31 | 13G | Poseida Therapeutics, Inc. PSTX |
NOVARTIS INC | 5,908,089 9.600% |
5,908,089 (New Position) |
Filing History |
| 2021-02-08 10:31 am Purchase |
2021-02-05 | 13G | Poseida Therapeutics, Inc. PSTX |
FMR CORP | 9,273,001 14.999% |
619 (+0.01%) |
Filing History |
| 2021-02-03 06:15 am Purchase |
2020-07-14 | 13G | Poseida Therapeutics, Inc. PSTX |
Malin Life Sciences Holdings Limited | 9,188,125 14.900% |
9,188,125 (New Position) |
Filing History |
| 2020-12-28 4:05 pm Purchase |
2020-12-16 | 13D | Poseida Therapeutics, Inc. PSTX |
Pentwater Capital Management LP | 4,967,227 8.030% |
4,967,227 (New Position) |
Filing History |